NCT03557931: A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication |
|
|
| Completed | 2a | 233 | US | ASP4345, placebo, risperidone, Risperdal, quetiapine, Seroquel, olanzapine, Zyprexa, ziprasidone, Geodon, aripiprazole, Abilify, brexpiprazole, Rexulti, paliperidone, Invega, lurasidone, Latuda | Astellas Pharma Global Development, Inc. | Schizophrenia | 10/19 | 10/19 | | |
NCT00044044: A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia |
|
|
| Completed | 2 | 356 | US | Lurasidone 20 mg, Lurasidone 40mg, Lurasidone 80 mg, Haloperidol 10mg, Placebo | Sunovion | Schizophrenia | 05/03 | 05/03 | | |